Acute generalized exanthematous pustulosis: European expert consensus for diagnosis and management

Archive ouverte

Tetart, F. | Walsh, S. | Milpied, B. | Gaspar, K. | Vorobyev, A. | Tiplica, G. | Didona, B. | Welfringer-Morin, A. | Kucinskiene, V. | Bensaid, B. | Marvanova, E. | Salavastru, C. | Brezinova, E. | Chua, S. | Lovgren, M. | Hammers, C. | Barbaud, A. | Mortz, C. | Horvath, B. | Meyersburg, D. | Lebrun-Vignes, B. | Bodemer, C. | Brüggen, M. | French, L. | Ingen-Housz-Oro, S.

Edité par CCSD ; Wiley -

International audience. Abstract Acute generalized exanthematous pustulosis (AGEP) is a rare, usually drug‐induced, acute pustular rash. Despite the lack of strong data supporting the effectiveness of topical or systemic corticosteroids in this drug reaction, they are widely used. More generally, there is no consensus on the diagnostic modalities and the management of patients with AGEP. We aimed to provide European expert recommendations for the diagnosis and management or patients with AGEP. Members of the ToxiTEN group of the European Reference Network (ERN)‐skin, all dermatologists and/or allergologists with expertise in drug reactions, elaborated these recommendations based on their own experience and on a review of the literature. Recommendations were separated into the following categories: professionals involved, assessment of the diagnosis of AGEP, management of the patient and allergological work‐up after the acute phase. Consensus was obtained among experts for the list of professionals involved for the diagnosis and management of AGEP, including the minimum diagnostic work‐up, the setting of management, the treatments, the modalities and the timing of allergological work‐up and follow‐up. European experts in drug allergies propose herein consensus on the diagnosis and management of patients with AGEP. A multidisciplinary approach is warranted, including dermatologists, allergologists and pharmacovigilance services.

Consulter en ligne

Suggestions

Du même auteur

Post-acute phase and sequelae management of epidermal necrolysis: an international, multidisciplinary DELPHI-based consensus

Archive ouverte | Ingen-Housz-Oro, S. | CCSD

International audience. Abstract Background Long-term sequelae are frequent and often disabling after epidermal necrolysis (Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN)). However, consensus on...

Supportive care in the acute phase of Stevens–Johnson syndrome and toxic epidermal necrolysis: an international, multidisciplinary Delphi‐based consensus

Archive ouverte | Brüggen, M.‐c. | CCSD

International audience. Background: Supportive care is the cornerstone of management of adult and paediatric Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). However, consensus on the modalities ...

Hypersensibilité retardée aux traitements antituberculeux. Proposition d’une conduite à tenir pratique devant un exanthème : quand arrêter, quelles explorations allergologiques et comment réintroduire le traitement

Archive ouverte | Ingen-Housz-Oro, S. | CCSD

International audience

Chargement des enrichissements...